Isolation and purification of surface antigens from disrupted paramyxoviruses.
D000956:Antigens, Viral / Q000032:analysis / Q000302:isolation & purification*; D002499:Centrifugation, Density Gradient; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D003840:Deoxycholic Acid; D004591:Electrophoresis, Polyacrylamide Gel; D006023:Glycoproteins / Q000032:analysis; D006385:Hemagglutination Inhibition Tests; D006389:Hemagglutinins, Viral / Q000032:analysis / Q000302:isolation & purification*; D009439:Neuraminidase / Q000032:analysis / Q000302:isolation & purification*; D009522:Newcastle disease virus / Q000201:enzymology / Q000276:immunology; D010222:Parainfluenza Virus 1, Human / Q000201:enzymology / Q000276:immunology; D010252:Paramyxoviridae / Q000276:immunology; D010447:Peptide Hydrolases; D018108:Respirovirus / Q000201:enzymology / Q000276:immunology; D012995:Solubility; D013501:Surface-Active Agents
D000956:Antigens, Viral; D006023:Glycoproteins; D006389:Hemagglutinins, Viral; D013501:Surface-Active Agents; D003840:Deoxycholic Acid; D009439:Neuraminidase; D010447:Peptide Hydrolases